Search is Powered by Google
Cancer / Oncology News

Removing both breasts reduces cancer risk by 90%

Main Category: Cancer / Oncology
Article Date: 25 Feb 2004 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

A double preventive mastectomy reduces the chance of breast cancer in women who are genetically prone to the disease by 90%.

This is according to research carried out by the University of Pennsylvania, the report is also published in the Journal of Clinical Oncology.

The removal of the ovaries also makes HRT safe for these women.

The six-year study examined women who carry the BRCA1 or BRCA2 gene, which greatly raises the risk of breast and ovarian cancer.

The researchers found just two cases of cancer among 105 women who had both breasts removed as a prophylactic measure - a cancer rate of 1.9 per cent. The study included women from Britain, the United States and the Netherlands.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...